[1] Pfaller M A, Diekema D J, Gibbs D L, et al. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005[J]. J Clin Microbiol, 2008,46(3):842-849.[2] Reissa E, Lasker B A, Iqbal N J, et al. Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units[J]. Infect Genet Evol, 2008,8(2):103-109.[3] van Asbeck E C, Huang Y C, Markham A N, et al. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies[J]. Mycopathologia, 2007,164(6):287-293.[4] Rossignol T, Ding C, Guida A, et al. Correlation between biofilm formation and the hypoxic response in Candida parapsilosis[J]. Eukaryot Cell, 2009,8(4):550-559.[5] Douglas L J. Candida biofilms and their role in infection[J]. Trends Microbiol, 2003,11(1):30-36.[6] Yeater K M, Chandra J, Cheng G, et al. Temporal analysis of Candida albicans gene expression during biofilm development[J]. Microbiology, 2007,153(pt8):2373-2385.[7] 杨继君,陈兴平.白念珠菌生物膜形成不同时期对氟康唑的敏感性[J].华中科技大学学报:医学版,2007,36(6):773-775.[8] 路秀文,张照亮,由军,等.念珠菌生物膜的检测及其耐药性分析[J].实用检验医师杂志,2010,2(2):96-98.[9] 曾昭瑛,苏建荣.抗念珠菌药物的耐药特性分析[J].首都医科大学学报,2012,33(2):169-176.[10] Kuhn D M, Chandra J, Mukherjee P K, et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces[J]. Infect Immun, 2002,70(2):878-888.[11] Bruzual I, Riggle P, Hadley S, et al. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole[J]. J Antimicrob Chemother, 2007,59(3):441-450.[12] Wan Harun W H, Jamil N A, Jamaludin N H, et al. Effect of Piper betle and Brucea javanica on the Differential Expression of Hyphal Wall Protein(HWP1) in Non-Candida albicans Candida(NCAC) Species[J]. Evid Based Complement Alternat Med, 2013,397268. |